EQS-News: Cheplapharm AG / Key word(s): Annual Results/Annual ReportCHEPLAPHARM closes financial year 2023 with record revenue and double-digit growth 26.04.2024 / 11:55 CET/CESTThe issuer is solely responsible for the content of this announcement.CHEPLAPHARM CLOSES FINANCIAL YEAR 2023 WITH RECORD REVENUE AND DOUBLE.
EQS-Media / 21.09.2023 / 13:41 CET/CESTCHEPLAPHARM Arzneimittel GmbH (“CHEPLAPHARM” or the “Company”), a leading international platform for well-established branded medicines, took advantage of the currently favorable market conditions and successfully placed additional senior secured notes with a total volume of €3.
EQS-News: CHEPLAPHARM places notes in a volume of 750m in challenging market environment finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.
DGAP-News: Cheplapharm AG / Key word(s): Half Year ResultsCHEPLAPHARM INCREASES REVENUE AND EARNINGS IN THE FIRST HALF OF 2022eplapharm AG: 29.08.2022 / 16:06 CET/CESTThe issuer is solely responsible for the content of this announcement.CHEPLAPHARM INCREASES REVENUE AND EARNINGS IN THE FIRST HALF OF 2022 Reve.